ROLE OF BISULFITE IN DEBROMINATION OF 5-BROMOURACIL - DEBROMINATION OF 5-BROMO-5,6-DIHYDROURACIL-6-SULFONATE

被引:11
作者
SEDOR, FA [1 ]
SANDER, EG [1 ]
机构
[1] UNIV FLORIDA,DEPT BIOCHEM,GAINESVILLE,FL 32610
关键词
D O I
10.1016/0003-9861(74)90347-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:632 / 637
页数:6
相关论文
共 17 条
[1]   DEHALOGENATION OF SUBSTITUTED PYRIMIDINES INVIVO [J].
BARRETT, HW ;
WEST, RA .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1956, 78 (08) :1612-1615
[2]  
COOPER GM, 1970, CANCER RES, V30, P2937
[3]  
COTTON FA, 1966, ADV INORGANIC CHEMIS
[4]  
DORSETT MT, 1969, CANCER RES, V29, P79
[5]   GENERAL ACID-BASE CATALYSIS OF REVERSIBLE ADDITION OF BISULFITE TO 1,3-DIMETHYLURACIL [J].
ERICKSON, RW ;
SANDER, EG .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1972, 94 (06) :2086-&
[6]  
KALLEN RG, 1966, J BIOL CHEM, V241, P5851
[7]  
KRISS JP, 1962, CANCER RES, V22, P254
[8]   SOME ASPECTS OF THE METABOLISM OF 5-BROMOURACIL [J].
PAHL, HB ;
GORDON, MP ;
ELLISON, RR .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1959, 79 :245-251
[9]   STUDIES IN THE MOUSE OF THE PHARMACOLOGY OF 5-IODODEOXYURIDINE, AN ANALOGUE OF THYMIDINE [J].
PRUSOFF, WH ;
JAFFE, JJ ;
GUNTHER, H .
BIOCHEMICAL PHARMACOLOGY, 1960, 3 (02) :110-121
[10]  
SANDER E, UNPUBLISHED RESULTS